These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2019237)

  • 1. Factors predicting residual beta-cell function in the first year after diagnosis of childhood type 1 diabetes.
    Couper JJ; Hudson I; Werther GA; Warne GL; Court JM; Harrison LC
    Diabetes Res Clin Pract; 1991 Jan; 11(1):9-16. PubMed ID: 2019237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis.
    Wallensteen M; Dahlquist G; Persson B; Landin-Olsson M; Lernmark A; Sundkvist G; Thalme B
    Diabetologia; 1988 Sep; 31(9):664-9. PubMed ID: 3069534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble CD8 antigen, stimulated C-peptide and islet cell antibodies are predictors of insulin requirement in newly diagnosed patients with unclassifiable diabetes.
    Di Bonito P; De Bellis A; Capaldo B; Turco S; Corigliano G; Pace E; Bizzarro A
    Acta Diabetol; 1996 Sep; 33(3):220-4. PubMed ID: 8904929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural course of remission in IDDM during 1st yr after diagnosis.
    Martin S; Pawlowski B; Greulich B; Ziegler AG; Mandrup-Poulsen T; Mahon J
    Diabetes Care; 1992 Jan; 15(1):66-74. PubMed ID: 1737543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.
    Chaillous L; Lefèvre H; Thivolet C; Boitard C; Lahlou N; Atlan-Gepner C; Bouhanick B; Mogenet A; Nicolino M; Carel JC; Lecomte P; Maréchaud R; Bougnères P; Charbonnel B; Saï P
    Lancet; 2000 Aug; 356(9229):545-9. PubMed ID: 10950231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children.
    Sochett EB; Daneman D; Clarson C; Ehrlich RM
    Diabetologia; 1987 Jul; 30(7):453-9. PubMed ID: 3311859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus.
    Bonfanti R; Bazzigaluppi E; Calori G; Riva MC; Viscardi M; Bognetti E; Meschi F; Bosi E; Chiumello G; Bonifacio E
    Diabet Med; 1998 Oct; 15(10):844-50. PubMed ID: 9796885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Factors affecting C-peptide level during the first year of type 1 diabetes in children].
    Zmysłowska A; Szadkowska A; Andrzejewski W; Wegner O; Wyka K; Młynarski W; Bodalski J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):103-11. PubMed ID: 15504313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis.
    Mortensen HB; Swift PG; Holl RW; Hougaard P; Hansen L; Bjoerndalen H; de Beaufort CE; Knip M;
    Pediatr Diabetes; 2010 Jun; 11(4):218-26. PubMed ID: 19708904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age, sex and ICA influence on beta-cell secretion during the first year after the diagnosis of type 1 diabetes mellitus.
    Montaña E; Fernandez-Castañer M; Rosel P; Gomez J; Soler J
    Diabete Metab; 1991; 17(5):460-8. PubMed ID: 1752347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus.
    Landin-Olsson M; Nilsson KO; Lernmark A; Sundkvist G
    Diabetologia; 1990 Sep; 33(9):561-8. PubMed ID: 2253834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased reduction in fasting C-peptide is associated with islet cell antibodies in type 1 (insulin-dependent) diabetic patients.
    Marner B; Agner T; Binder C; Lernmark A; Nerup J; Mandrup-Poulsen T; Walldorff S
    Diabetologia; 1985 Dec; 28(12):875-80. PubMed ID: 3912242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketoacidosis at diagnosis is predictive of lower residual beta-cell function and poor metabolic control in type 1 diabetes.
    Fernandez Castañer M; Montaña E; Camps I; Biarnes J; Merino JF; Escriba JM; Nacher V; Rosel P; Soler J
    Diabetes Metab; 1996 Oct; 22(5):349-55. PubMed ID: 8896997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis.
    Redondo MJ; Rodriguez LM; Escalante M; Smith EO; Balasubramanyam A; Haymond MW
    Pediatr Diabetes; 2013 Aug; 14(5):333-40. PubMed ID: 23458188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.
    Pozzilli P; Pitocco D; Visalli N; Cavallo MG; Buzzetti R; Crinò A; Spera S; Suraci C; Multari G; Cervoni M; Manca Bitti ML; Matteoli MC; Marietti G; Ferrazzoli F; Cassone Faldetta MR; Giordano C; Sbriglia M; Sarugeri E; Ghirlanda G
    Diabetologia; 2000 Aug; 43(8):1000-4. PubMed ID: 10990077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet-cell antibodies and endogenous insulin secretion in Sudanese diabetic children.
    Elamin A; Omer MI; Tuvemo T
    Diabetes Res Clin Pract; 1992 May; 16(2):91-6. PubMed ID: 1600856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor beta-cell function after the clinical manifestation of type 1 diabetes in children initially positive for islet cell specific autoantibodies. The Childhood Diabetes in Finland Study Group.
    Komulainen J; Knip M; Lounamaa R; Vähäsalo P; Karjalainen J; Sabbah E; Akerblom HK
    Diabet Med; 1997 Jul; 14(7):532-7. PubMed ID: 9223390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin Dose.
    Hao W; Gitelman S; DiMeglio LA; Boulware D; Greenbaum CJ;
    Diabetes Care; 2016 Oct; 39(10):1664-70. PubMed ID: 27422577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships among islet cell antibodies, residual beta-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a sensitive C-peptide radioimmunoassay.
    Nakanishi K; Kobayashi T; Miyashita H; Ohkubo M; Sugimoto T; Murase T; Kosaka K; Inouye K; Kono M
    Metabolism; 1990 Sep; 39(9):925-30. PubMed ID: 2202883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Bacillus Calmette-Guerin vaccination on new-onset type 1 diabetes. A randomized clinical study.
    Allen HF; Klingensmith GJ; Jensen P; Simoes E; Hayward A; Chase HP
    Diabetes Care; 1999 Oct; 22(10):1703-7. PubMed ID: 10526739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.